A detailed history of Bill Miller (Miller Value Partners, LLC) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Miller Value Partners, LLC holds 80,000 shares of BMY stock, worth $4.71 Million. This represents 2.34% of its overall portfolio holdings.

Number of Shares
80,000
Previous 60,000 33.33%
Holding current value
$4.71 Million
Previous $2.49 Billion 66.11%
% of portfolio
2.34%
Previous 1.59%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $793,199 - $1.04 Million
20,000 Added 33.33%
80,000 $4.14 Billion
Q1 2024

May 07, 2024

BUY
$47.98 - $54.4 $2.88 Million - $3.26 Million
60,000 New
60,000 $3.25 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track Bill Miller's Portfolio

Track Bill Miller Portfolio

Follow Bill Miller (Miller Value Partners, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miller Value Partners, LLC and Bill Miller with notifications on news.